South Korea · Delayed Price · Currency is KRW OSTEONIC Statistics
Total Valuation
OSTEONIC has a market cap or net worth of KRW 84.36 billion. The enterprise value is 91.85 billion.
| Market Cap | 84.36B |
| Enterprise Value | 91.85B |
Important Dates
The next estimated earnings date is Thursday, August 13, 2026.
| Earnings Date | Aug 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
OSTEONIC has 20.06 million shares outstanding. The number of shares has increased by 2.88% in one year.
| Current Share Class | 20.06M |
| Shares Outstanding | 20.06M |
| Shares Change (YoY) | +2.88% |
| Shares Change (QoQ) | -4.46% |
| Owned by Insiders (%) | 20.17% |
| Owned by Institutions (%) | 6.76% |
| Float | 14.96M |
Valuation Ratios
The trailing PE ratio is 9.17 and the forward PE ratio is 7.34.
| PE Ratio | 9.17 |
| Forward PE | 7.34 |
| PS Ratio | 1.73 |
| PB Ratio | 1.20 |
| P/TBV Ratio | 1.28 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 8.83 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 9.78 |
| EV / Sales | 1.88 |
| EV / EBITDA | 7.08 |
| EV / EBIT | 9.99 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.18, with a Debt / Equity ratio of 0.40.
| Current Ratio | 2.18 |
| Quick Ratio | 1.34 |
| Debt / Equity | 0.40 |
| Debt / EBITDA | 2.16 |
| Debt / FCF | -19.98 |
| Interest Coverage | 7.71 |
Financial Efficiency
Return on equity (ROE) is 14.32% and return on invested capital (ROIC) is 10.93%.
| Return on Equity (ROE) | 14.32% |
| Return on Assets (ROA) | 5.64% |
| Return on Invested Capital (ROIC) | 10.93% |
| Return on Capital Employed (ROCE) | 11.07% |
| Weighted Average Cost of Capital (WACC) | 6.67% |
| Revenue Per Employee | 237.88M |
| Profits Per Employee | 45.82M |
| Employee Count | 205 |
| Asset Turnover | 0.48 |
| Inventory Turnover | 1.24 |
Taxes
In the past 12 months, OSTEONIC has paid 1.48 billion in taxes.
| Income Tax | 1.48B |
| Effective Tax Rate | 13.62% |
Stock Price Statistics
The stock price has decreased by -40.65% in the last 52 weeks. The beta is 0.62, so OSTEONIC's price volatility has been lower than the market average.
| Beta (5Y) | 0.62 |
| 52-Week Price Change | -40.65% |
| 50-Day Moving Average | 5,524.80 |
| 200-Day Moving Average | 6,417.10 |
| Relative Strength Index (RSI) | 23.20 |
| Average Volume (20 Days) | 185,739 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, OSTEONIC had revenue of KRW 48.77 billion and earned 9.39 billion in profits. Earnings per share was 458.80.
| Revenue | 48.77B |
| Gross Profit | 23.71B |
| Operating Income | 9.20B |
| Pretax Income | 10.87B |
| Net Income | 9.39B |
| EBITDA | 12.96B |
| EBIT | 9.20B |
| Earnings Per Share (EPS) | 458.80 |
Balance Sheet
The company has 20.61 billion in cash and 27.99 billion in debt, with a net cash position of -7.37 billion or -367.50 per share.
| Cash & Cash Equivalents | 20.61B |
| Total Debt | 27.99B |
| Net Cash | -7.37B |
| Net Cash Per Share | -367.50 |
| Equity (Book Value) | 70.23B |
| Book Value Per Share | 3,495.05 |
| Working Capital | 33.44B |
Cash Flow
In the last 12 months, operating cash flow was 9.55 billion and capital expenditures -10.95 billion, giving a free cash flow of -1.40 billion.
| Operating Cash Flow | 9.55B |
| Capital Expenditures | -10.95B |
| Depreciation & Amortization | 3.77B |
| Net Borrowing | 5.05B |
| Free Cash Flow | -1.40B |
| FCF Per Share | -69.83 |
Margins
Gross margin is 48.62%, with operating and profit margins of 18.86% and 19.26%.
| Gross Margin | 48.62% |
| Operating Margin | 18.86% |
| Pretax Margin | 22.30% |
| Profit Margin | 19.26% |
| EBITDA Margin | 26.59% |
| EBIT Margin | 18.86% |
| FCF Margin | n/a |
Dividends & Yields
OSTEONIC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 0.00% |
| Buyback Yield | -2.88% |
| Shareholder Yield | -2.88% |
| Earnings Yield | 11.13% |
| FCF Yield | -1.66% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on June 24, 2020. It was a forward split with a ratio of 1.5.
| Last Split Date | Jun 24, 2020 |
| Split Type | Forward |
| Split Ratio | 1.5 |
Scores
OSTEONIC has an Altman Z-Score of 3.06 and a Piotroski F-Score of 6.
| Altman Z-Score | 3.06 |
| Piotroski F-Score | 6 |